High-Density Lipoprotein Predicts Intrahospital Mortality in Influenza

Matthias Wolfgang Heinzl,Markus Freudenthaler,Paul Fellinger,Lisa Kolenchery,Michael Resl,Carmen Klammer,Florian Obendorf,Lukas Schinagl,Thomas Berger,Margot Egger,Benjamin Dieplinger,Martin Clodi
DOI: https://doi.org/10.3390/jcm13237242
IF: 3.9
2024-11-29
Journal of Clinical Medicine
Abstract:Background: Although it is known that high-density lipoprotein (HDL) exerts important anti-inflammatory effects and that low HDL plasma concentrations represent a negative prognostic marker in bacterial infections and sepsis, not much is known about possible implications of HDL in acute viral infections such as influenza. Methods: We performed a retrospective, single-centre analysis of influenza patients hospitalised during the 2018/19 and 2019/20 influenza seasons and analysed the impact of HDL concentrations on inflammation and mortality. Results: 199 influenza patients (173 male patients) were admitted during the 2018/19 and 2019/20 influenza seasons with a mortality rate of 4.5%. HDL was significantly lower in deceased patients (median HDL 21 (IQR 19–25) vs. 35 (IQR 28–44) mg/dL; p = 0.005). Low HDL correlated with increased inflammation and HDL was an independent negative predictor regarding mortality after correction for age and the number of comorbidities both overall (OR = 0.890; p = 0.008) and in male patients only (OR = 0.891; p = 0.009). Conclusions: Low HDL upon hospital admission is associated with increased inflammation and is an independent predictor for increased mortality in male patients with influenza A.
medicine, general & internal
What problem does this paper attempt to address?